• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: April 1-5


ICYMI, this week we had news about Ycanth's J-code launch, highlights from Diversity in Dermatology, bimekizumab's accepted sBLA for HS, and more.

Dermatology Times Weekly Roundup logo - Image credit: Dermatology Times

Credit: Dermatology Times

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Dermatology Conferences and Meetings Calendar 2024: April

Dermatology Times asked our readers to share what conferences they are looking forward to in the second quarter of 2024.

Sexually Dimorphic Inflammatory Responses Key to Understanding Vitiligo, Study Finds

The study uncovered sexual dimorphism in melanocyte stem cell migration rates due to UVB-induced inflammatory responses in mice.

J-Code for Ycanth Officially Launches Today

The permanent J-code for the molluscum contagiosum treatment is now live.

Artificial Intelligence Mode Demonstrates Accuracy in the Prediction of Skin Cancer Risk Using 2D Images

An XAI AI model using 2D facial images accurately predicted skin cancer better than traditional factors, according to a study advocating for AI-driven screening.

Incyte and CMS Collaborate to Develop Povorcitinib in Numerous Chinese Regions

Povorcitinib is being evaluated for non-segmental vitiligo, hidradenitis suppurativa, prurigo nodularis, asthma, and chronic spontaneous urticaria.

Mastering the Challenges of Adult Female Acne in Primary Care in 2024

Over 50% of women in their 20s and over 35% of women aged 30 to 39 years struggle with adult female cystic acne.

Patients With Vitiligo Show Lower Pulmonary Embolism and Peripheral Vascular Disease Risk, but Mortality Rises with Comorbidities

A recent study aimed to investigate the risk of myocardial infarction, cerebrovascular accident, peripheral vascular disease, and pulmonary embolism in patients with vitiligo.

Mona Shahriari, MD, FAAD: 'The Days of Paternalistic Medicine Are Gone'

Shahriari shares pearls and considerations from her sessions at the recent Diversity in Dermatology conference.

Recapping March Dermatology Biosimilar News

The biosimilar landscape experienced significant activity, marked by fresh data from conferences, novel findings regarding adalimumab biosimilars, and more.

Muneeb Shah, DO: Behind the Scenes of Launching a Skin Care Brand

Shah discusses the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.

Microneedling With and Without N-acetylcysteine Prove Effective in Patients With Persistent Vitiligo

While the addition of NAC yielded greater improvement than microneedling alone, this difference was not significant.

Soligenix and European Medicines Agency Settle on Design of Second Placebo-Controlled Trial of HyBryte in CTCL

The agreement for a second confirmatory trial comes after a successful phase 3 FLASH study that yielded positive outcomes and efficacy.

ARCA Biopharma and Oruka Therapeutics Agree to Merger

The merger will focus on advancing Oruka’s portfolio of novel biologics for the treatment of chronic skin diseases.

Pelthos Therapeutics Launches to Accelerate Commercialization of Treatment for Molluscum Contagiosum

The new launch is set to bring berdazimer topical gel, 10.3% to adults and pediatric patients over the age of 1 with molluscum contagiosum faster.

Pointers With Portela: Effects of Hormone Changes on the Skin

In this week’s Pointers With Portela, the 208SkinDoc reviews how the skin is affected during hormonal changes and menopause.

New Data on Retinol: Patricia Farris, MD, Shares Insights on Anti-Aging

In this study, topical 0.1% retinol significantly improved crow’s feet, facial wrinkles, uneven skin tone, brown spots, and overall photoaging.

Elevated Plasma Calcitonin Gene-Related Peptide Levels in Patients With Rosacea May Open Door for New Therapeutic Approaches

One study uncovered high levels of CGRP in patients with rosacea, with levels not affected by age, sex, BMI, and other factors.

Dupilumab Shows Superiority in Reducing Upper Respiratory Infections in Patients With AD

The risk of upper respiratory infection-related mortality was notably diminished in the study's dupilumab cohort.

FDA Accepts Supplemental Biologics License Applications for Bimekizumab to Treat HS

The submission stems from promising results from the phase 3 BE HEARD I and BE HEARD II trials.

Topical Melatonin and Rosuvastatin Reduce Severity of Mild to Moderate Plaque Psoriasis

Versus placebo, topical melatonin and rosuvastatin reduced psoriatic plaque severity with a favorable safety profile.

Botulinum Toxin, Dermal Fillers Generally Effective and Well-Tolerated in Skin of Color Populations

In a literature review, researchers found data supporting the efficacy and safety of fillers in patients with skin of color, particularly for populations where is there is limited data.

Journal Digest: April 4

This week’s collection of the latest dermatologic studies covers topical permethrin 5% vs. benzyl benzoate 25% for scabies, the safety of omalizumab in CSU during pregnancy, symptoms of cognitive impairment in children with AD, and the ethics of cosmetic overtreatment.

Be Proactive When Combatting Tanning Bed Misinformation on Social Media

Influencers promote the use of tanning beds and list the “benefits,” such as obtaining vitamin D and helping with seasonal affective disorder, among other reasons that have no merit.

Managing Mental Health Comorbidities in Adult Patients With Atopic Dermatitis

Researchers address the persisting gaps in managing mental health comorbidities within the framework of existing clinical practice guidelines.

Omalizumab for Chronic Spontaneous Urticaria Does Not Yield Negative Maternal, Fetal Outcomes in Pregnancy

Researchers reviewed the efficacy and safety of omalizumab in patients with severe CSU in a routine clinical practice setting.

Topical Permethrin Demonstrates Lack of Efficacy Compared to Benzyl Benzoate in Most Scabies Cases

In a comparative study, benzyl benzoate demonstrated superior efficacy in scabies cases, while topical permethrin exhibited a lack of effectiveness.

Countdown to RAVE!

Three distinct congresses known as RAVE (Revolutionizing Atopic Dermatitis, Alopecia Areata, and Vitiligo) will be held June 8-10, in Chicago, Illinois.

Increased Levels of B-Type Natriuretic Peptide May be Associated With Various Types of Chronic Itch

Gil Yosipovitch, MD, discusses the correlation between increased BNP levels and chronic pruritus of unknown origin.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.